Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 80.95
-0.80 (-0.98%)
At close: Dec 16, 2025
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 138.73 billion as of December 16, 2025. Its market cap has increased by 128.30% in one year.
Market Cap
138.73B
Enterprise Value
131.98B
Revenue
12.52B
Ranking
n/a
PE Ratio
109.50
Stock Price
80.95
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 138.73B, an increase of 648.32%. That is a compound annual growth rate of 32.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 138.73B | 131.39% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | 115.10B | 243.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 267.53B |
| Hansoh Pharmaceutical Group Company | 240.58B |
| JD Health International | 183.44B |
| WuXi Biologics | 132.35B |
| Sino Biopharmaceutical | 115.48B |
| Akeso | 107.68B |
| Sichuan Kelun-Biotech Biopharmaceutical | 93.88B |
| WuXi XDC Cayman | 86.35B |